Holen Sie sich die Stockscreener-App
71.03
2.05%
-1.49
Handel nachbörslich:
71.03
Schlusskurs vom Vortag:
$72.52
Offen:
$70.7
24-Stunden-Volumen:
1.30M
Relative Volume:
2.12
Marktkapitalisierung:
$3.91B
Einnahmen:
$76.81M
Nettoeinkommen (Verlust:
$-162.42M
KGV:
-23.76
EPS:
-2.99
Netto-Cashflow:
$-122.49M
1W Leistung:
+0.51%
1M Leistung:
+2.97%
6M Leistung:
+11.49%
1J Leistung:
+17.13%
1-Tages-Spanne:
$66.52
$73.03
1-Wochen-Bereich:
$66.52
$74.88
52-Wochen-Spanne:
$47.86
$107.37
Arcellx Inc Stock (ACLX) Company Profile
Firmenname
Arcellx Inc
Sektor
Branche
Telefon
240-327-0603
Adresse
800 BRIDGE PARKWAY, REDWOOD CITY
Vergleichen Sie ACLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACLX
Arcellx Inc
|
71.03 | 3.83B | 76.81M | -162.42M | -122.49M | -2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Eingeleitet | Citigroup | Buy |
| 2024-10-08 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-03 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-01-04 | Bestätigt | Needham | Buy |
| 2023-12-19 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-10-30 | Eingeleitet | TD Cowen | Outperform |
| 2023-10-17 | Eingeleitet | UBS | Buy |
| 2023-05-18 | Eingeleitet | Truist | Buy |
| 2023-04-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-14 | Eingeleitet | Stifel | Buy |
| 2023-02-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-13 | Fortgesetzt | BofA Securities | Buy |
| 2022-10-31 | Eingeleitet | Guggenheim | Buy |
| 2022-10-27 | Eingeleitet | Needham | Buy |
| 2022-07-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-03-01 | Eingeleitet | BofA Securities | Buy |
| 2022-03-01 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Arcellx Inc Aktie (ACLX) Neueste Nachrichten
Widening Losses in Q2 and H1 Might Change the Case for Investing in Arcellx (ACLX) - simplywall.st
Evercore ISI Maintains Buy Rating on Arcellx Inc with $115 Price Target - AInvest
Arcellx, Inc. Reports Increased Losses Amid Rising R&D Costs - TipRanks
Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Nektar Therapeutics (NKTR) - The Globe and Mail
Analysts Have Lowered Expectations For Arcellx, Inc. (NASDAQ:ACLX) After Its Latest Results - simplywall.st
We Think Arcellx (NASDAQ:ACLX) Can Afford To Drive Business Growth - uk.finance.yahoo.com
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $105 to $134 - 富途牛牛
Long term hold vs stop loss in Arcellx Inc.Free Stable Entry High Return Opportunities - Newser
Can you recover from losses in Arcellx Inc.Fast Return Equity Forecast With Logic - Newser
Using Ichimoku Cloud for Arcellx Inc. technicalsOversold Opportunity Scanner with RSI Data - Newser
Using Bollinger Bands to evaluate Arcellx Inc.Near-Term Market Opportunity Forecast Sheet - Newser
Applying big data sentiment scoring on Arcellx Inc.Secure Buy Strategy Based on Risk Parameters - Newser
Has Arcellx Inc. formed a bullish divergenceFree Weekly Potential Breakout Stock List - Newser
Real time scanner hits for Arcellx Inc. explainedFree Value Investing Picks With Stability - Newser
Historical volatility pattern of Arcellx Inc. visualizedFree Swing Trading Plan With Smart Signals - Newser
Published on: 2025-08-08 23:14:52 - Newser
Arcellx Inc. stock volume spike explainedLoss Limitation Strategy Based on Analysis - Newser
Did Widening Losses and Falling Sales Just Shift Arcellx's (ACLX) Investment Narrative? - simplywall.st
Arcellx 2025 Q2 Earnings Deepened Losses Amid Declining Revenue - AInvest
Does Arcellx Inc. have a sustainable dividendShort-Term Explosive Growth - thegnnews.com
Promising Prospects for Arcellx Inc: Strong Efficacy and Strategic Partnerships Drive Buy Rating - TipRanks
Arcellx shares rise 3.32% intraday after reporting positive Q2 2025 financial results and potential life-changing therapy for multiple myeloma patients. - AInvest
Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights - BioSpace
Promising Outlook for Arcellx Inc.: Buy Rating Backed by Strong Anito-cel Therapy Performance and Favorable Safety Profile - TipRanks
Arcellx earnings beat by $0.08, revenue fell short of estimates - Investing.com Canada
Arcellx Inc: Promising Developments and Strong Clinical Data Drive Buy Rating - TipRanks
Arcellx Inc Shares Dip Amid Revenue Concerns - TipRanks
Arcellx reports Q2 EPS (94c), consensus ($1.03) - TipRanks
Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Arcellx Q2 Revenue Misses Estimates, Adjusted EPS Beats Consensus - AInvest
Earnings Flash (ACLX) Arcellx, Inc. Reports Q2 Revenue $7.6M, vs. FactSet Est of $13.5M - MarketScreener
Arcellx (ACLX) to Release Quarterly Earnings on Thursday - Defense World
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Why Arcellx Inc. stock attracts strong analyst attentionFree Capital Protection Trading Strategies - Newser
Cantor Fitzgerald Comments on Arcellx FY2025 Earnings - Defense World
Three Stocks Showing Strong Buy Signals - AInvest
Cantor Fitzgerald Upgrades Arcellx (NASDAQ:ACLX) to Strong-Buy - Defense World
Pattern recognition hints at Arcellx Inc. upsideReal-Time Entry Signals for Top Stocks - Newser
Bollinger Band Squeeze Points to Volatility in Arcellx Inc.Scalable Portfolio Growth Suggestions Released - metal.it
Does Arcellx Inc. stock perform well during market downturnsAccelerated profit realization - Jammu Links News
Why is Arcellx Inc. stock attracting strong analyst attentionHigh-profit capital plays - Jammu Links News
Should I hold or sell Arcellx Inc. stock in 2025Invest smarter with data-backed trading alerts - Jammu Links News
What is the dividend policy of Arcellx Inc. stockUnlock exclusive trading strategies for gains - Jammu Links News
What markets is CHEF expanding into Is Arcellx Inc. stock a good long term investment optionBuild a diversified portfolio for steady growth - Jammu Links News
Arcellx (NASDAQ:ACLX) Price Target Raised to $133.00 - Defense World
What analysts say about Arcellx Inc. stockAchieve consistent double-digit growth - Jammu Links News
What is Arcellx Inc. company’s growth strategyUnlock daily market insights for better decisions - Jammu Links News
What catalysts could drive Arcellx Inc. stock higher in 2025Build a portfolio that outperforms the market - Jammu Links News
When is Arcellx Inc. stock expected to show significant growthCapitalize on market momentum for maximum gains - Jammu Links News
Is it the right time to buy Arcellx Inc. stockTremendous gains - Jammu Links News
How does Arcellx Inc. generate profit in a changing economyUnlock steady growth with low-risk stocks - Jammu Links News
Finanzdaten der Arcellx Inc-Aktie (ACLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):